Products - Renal cancer | Topic | NICE

Showing 3 products

Date | Title

Status: In developmentRemove ‘Status: In development’ filter

Suspected Cancer: recognition and referral (update)
Status:
In development
Programme:
NICE guideline
Expected publication date:
15 April 2026
Renal cell carcinoma Pathways Pilot [ID6186]
Status:
In development
Programme:
Technology appraisal guidance
Expected publication date:
TBC
Savolitinib with durvalumab for treating MET-driven unresectable advanced papillary renal cell carcinoma [ID6520]
Status:
In development
Programme:
Technology appraisal guidance
Expected publication date:
TBC